RheumaGen Alternatives & Competitors

12 companies similar to RheumaGen — RheumaGen is developing an HLA gene editing platform to cure Rheumatoid Arthriti...

NewBiologix

Developing technologies for the biopharma industry to allow them to treat the root causes...

25 Series A $45.00M

Epalinges, Switzerland

Biotechnology Health Care +1

Tessera Therapeutics

Pioneering the future of genetic medicine with the power to rewrite the genome and cure di...

21 $682.70M

Biopharma Biotechnology +2

Affinia Therapeutics

Building the next generation of gene therapies

34 Series C $210.00M

Waltham, United States

Biotechnology Health Care +2

Taysha Gene Therapies

Taysha Gene Therapies is focused on advancing AAV-based gene therapies for severe monogeni...

134 IPO $802.30M

Dallas, United States

Biotechnology Life Sciences

Track all RheumaGen competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Apic Bio

Pioneering gene therapies for rare neurological and liver diseases, targeting Alpha-1 Anti...

Series A $53.32M

Biotechnology Health Care +2

Inspire Biotherapeutics Inc

Inspire is gene therapy platform company creating life-saving gene therapies for monogenic...

1 Pre-Seed

Biotechnology Life Sciences

Prilenia

Dedicated to developing new treatments for neurodegenerative diseases and neurodevelopment...

57 Series B $115.50M

Boston, United States

Biotechnology Health Care +2

Verve Therapeutics

Wholly owned subsidiary of Eli Lilly and Company

162 Acquired $2.03B

Boston, United States

Biotechnology Life Sciences +1

Edesa Biotech, Inc.

Clinical stage treatments for inflammatory and immune-related diseases (Nasdaq: EDSA)

20 Grant $53.00M

Markham, Canada

Biotechnology Life Sciences

Cytovas

Empowering precision medicine through a pioneering cell-based informatics platform, delive...

Venture round

Biotechnology Health Care +2

Rectify Pharma

Developing Positive Functional Modulators (PFMs) to restore and enhance membrane protein f...

20 Series A $100.00M

Boston, United States

Biotechnology Health and Wellness +1

Kinarus Therapeutics

Kinarus Therapeutics is a clinical-stage company developing therapies for viral, respirato...

5 Post-IPO Equity $36.55M

Basel, Switzerland

Biopharma Biotechnology +2

Frequently Asked Questions

Companies similar to RheumaGen include NewBiologix, Tessera Therapeutics, Affinia Therapeutics, Taysha Gene Therapies, Apic Bio. They work in Biotechnology and Life Sciences.

Bounce Watch lists 12 companies that share RheumaGen's industries and are closest to it in business tags, services, target customers, business model and size.

RheumaGen is a biotechnology startup based in the United States that is focused on developing a cutting-edge HLA gene editing platform to address Rheumatoid Arthritis and other autoimmune diseases. The company, established in 2019, is driven by the mission of creating a groundbreaking gene editing treatment with the po...

Don't just read about them. Follow them.

BounceWatch watches RheumaGen and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

RheumaGen Profile NewBiologix Alternatives Tessera Therapeutics Alternatives Affinia Therapeutics Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. The 12 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.